secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCardia, Inc. (BCDA)
CIK:        0000925741
Form:       8-K
Filed at:   2026-04-28T23:59:59+00:00
Accession:  0001437749-26-013535
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCardia announces allowance of Japanese patent for Heart3D Fusion Imaging software
--------------------------------------------------------------------------------

- Japanese patent allowed for 'Target Site Selection, Entry, and Update with Automatic Remote Image Annotation'.
- Patent protects Heart3D Fusion Imaging used for treatment planning and navigation during CardiAMP Cell Therapy procedures.
- Claims cover transposing pre-op CT/MRI 3D images onto 2D orthogonal images to generate combined 3D model in sterile field.
- Technology supports CardiAMP cell therapy for ischemic heart failure and Helix intramyocardial delivery system.
- Company working on Japan PMDA submission and US regulatory discussions for these product candidates.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/925741/000143774926013535/0001437749-26-013535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/925741/000143774926013535/bcda20260428_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-013535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer